Top Markets
#1 Black Phoenix Black Phoenix +354.79%
#2 Glidr Glidr +84.34%
#3 Akedo Akedo +76.58%
#4 Gold Park Gold Park +61.59%
#5 OpenEden OpenEden +47.95%
#6 Acurast Acurast +32.33%
#7 BasedHype BasedHype +27.12%
#8 Cryptopia Cryptopia +21.54%
#9 Avantis Avantis +20.48%
#10 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +20.03%
Coin of the day
Black Phoenix Black Phoenix
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
China Jo-Jo Drugstores, Inc. China Jo-Jo Drugstores, Inc.

China Jo-Jo Drugstores, Inc.

CJJD
Rang in Aktien #40595
China Jo-Jo Drugstores, Inc., along with its subsidiary entities, functions as... China Jo-Jo Drugstores, Inc., along with its subsidiary entities, functions as a prominent retailer and distributor of a wide array of pharmaceutical and healthcare products across the People's Republic of China. Its operations are structured into four distinct segments: retail pharmacies, an online drugstore, wholesale drug distribution, and the cultivation of medicinal herbs. The company's brick-and-mortar stores supply customers with diverse pharmaceutical items, including both prescription and over-the-counter medications, nutritional supplements, traditional Chinese remedies, personal and family care products, and medical devices. Beyond these, they also stock everyday convenience goods such as consumables, seasonal items, and promotional merchandise. To further enhance customer service, these locations feature licensed practitioners of both Western and Traditional Chinese Medicine, available at scheduled times for consultations, examinations, and the treatment of common ailments. Additionally, China Jo-Jo Drugstores operates an internet-based pharmacy, marketing over-the-counter medications and health supplements directly to consumers, as well as leveraging third-party e-commerce platforms for sales. The enterprise also engages in the wholesale supply of third-party pharmaceutical goods, primarily to trading companies, and manages the cultivation and distribution of herbs utilized in Traditional Chinese Medicine. As of March 31, 2021, the company maintained a network of 109 retail pharmacies operating under the 'Jiuzhou Grand Pharmacy' brand, supplemented by four other drugstores. Founded in 2003, the firm's corporate headquarters are situated in Hangzhou, People's Republic of China.
Aktienkurs
$1.05
Zuletzt synchronisiert: 2025-03-31
Marktkapitalisierung
$114.95K
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
CN
Handel China Jo-Jo Drugstores, Inc. (CJJD)

Kategorie

Healthcare
Gewinn für China Jo-Jo Drugstores, Inc. (CJJD)
Gewinn im Mar 2024 TTM: $-4.17M
Laut den aktuellen Finanzberichten von China Jo-Jo Drugstores, Inc. betragen die aktuellen Gewinne des Unternehmens $-4.17M. Im Jahr 2023 erzielte das Unternehmen einen Gewinn von $-20.74M, ein Rückgang im Vergleich zu dem Gewinn im Jahr 2022, der $-2.10M betrug. Die auf dieser Seite angezeigten Gewinne sind die Gewinne vor Zinsen und Steuern, auch bekannt als EBIT.
Gewinnverlauf von China Jo-Jo Drugstores, Inc. von 2007 bis 2026
Gewinn am Ende jedes Jahres
Jahr Gewinn ändert
2026 (TTM) $-4.17M 0.00%
2024 $-4.17M -79.89%
2023 $-20.74M 888.46%
2022 $-2.10M -74.85%
2021 $-8.34M 29.54%
2020 $-6.44M 444.50%
2019 $-1.18M -93.03%
2018 $-16.98M 205.47%
2017 $-5.56M -1,122.22%
2016 $543.90K -40.43%
2015 $913.03K -103.61%
2014 $-25.31M 81.04%
2013 $-13.98M -229.58%
2012 $10.79M -9.76%
2011 $11.96M -5.87%
2010 $12.70M 0.00%
2008 0.00 0.00%
2007 0.00 0.00%
Gewinn ähnlicher Unternehmen oder Konkurrenten
Unternehmen Gewinn Gewinnunterschied Land
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
$1.35B -32,460.18%
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
- -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
$26.37M -732.14%
US